PRVB Insider Trading Activity and SEC Form 4 Filings
PRVB insider trading summary
No open-market insider purchases or sales of Provention Bio, Inc. (PRVB) have been reported on SEC Form 4 in the past 12 months.
Latest PRVB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 14, 2023 | Sessa Capital (Master), L.P. | 10% Owner | Sell | $53.3M (2,190,549 @ $24.32) |
| Apr 14, 2023 | Sessa Capital IM, L.P. | 10% Owner | Sell | $53.3M (2,190,549 @ $24.32) |
| Apr 14, 2023 | John Petry | 10% Owner | Sell | $53.3M (2,190,549 @ $24.32) |
| Apr 14, 2023 | Sessa Capital IM GP, LLC | 10% Owner | Sell | $53.3M (2,190,549 @ $24.32) |
| Apr 14, 2023 | Sessa Capital GP, LLC | 10% Owner | Sell | $53.3M (2,190,549 @ $24.32) |
| Feb 13, 2023 | Francisco Leon | Chief Scientific Officer | Sell | $261K (25,985 @ $10.04) |
| Feb 13, 2023 | Ashleigh Palmer | Director and CEO | Sell | $259K (25,835 @ $10.04) |
| Feb 10, 2023 | Ashleigh Palmer | Director and CEO | Sell | $506K (50,000 @ $10.11) |
| Feb 10, 2023 | Francisco Leon | Chief Scientific Officer | Sell | $506K (50,000 @ $10.11) |
| Feb 10, 2023 | Jason Hoitt | Chief Commercial Officer | Sell | $45K (4,500 @ $10.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.